News | Treatment Planning | May 10, 2016

Australian Healthcare Network Adopts MIM Software Radiotherapy Planning Solution

MIM Maestro software suite offers advanced tools for image fusion, contouring, deformable registration and automation

May 10, 2016 — MIM Software Inc. announced that GenesisCare Australia has selected MIM Maestro as their radiotherapy contouring and deformable registration solutions platform across the Genesis Cancer Care Network in Australia.

Genesis Cancer Care is the largest provider of radiotherapy in Australia, performing over 300,000 yearly radiation oncology treatments from its network of 27 sites across the region. An extensive evaluation led to MIM Software being selected as the preferred suite of products to address the increasing demands of complex treatment protocols, resource-intensive workflows and high patient volumes.

"We are very excited to be partnering with MIM Software," explained Keith Hansen, national executive manager at Genesis Cancer Care. "A great deal of time and effort was spent in evaluating an optimal solution that would allow us to incorporate advanced processes and technologies into our patient care workflows. We are continuously striving to provide high-quality care for patients, with clinical excellence in image management and treatment planning, a key outcome required of the partnership. By implementing MIM into our clinics we will ensure every patient in our care receives highly personalised and highly targeted treatments."

MIM Maestro is a medical software suite capable of solving complex problems through the use of advanced tools for image fusion, contouring, deformable registration and automation to enhance radiation therapy plans.

For more information: www.mimsoftware.com

Related Content

The Aquilion Precision CT system from Canon offers very high resolution imaging, which may aid in cancer detection and improved treatment planning in radiation oncology. #ASTRO2018 #ASTRO #ASTRO18

The Aquilion Precision CT system from Canon offers very high resolution imaging, which may aid in cancer detection and improved treatment planning in radiation oncology. 

News | Computed Tomography (CT) | October 19, 2018
October 19, 2018 – At the 2018 American Society of...
IBA's Proteus system and proton therapy solutions will be discussed at ASTRO 2018. #ASTRO18 #ASTRO #ASTRO2018
News | Proton Therapy | October 19, 2018
October 19, 2018 – IBA (Ion Beam Applications S.A.) is sharing how hospitals can secure performance, investment and t
IBA Dosimetry Enters Interoperability Agreement With Varian for Dolphin Monitoring
News | Radiation Therapy | October 17, 2018
IBA (Ion Beam Applications S.A.) announced it has entered into an agreement with Varian with the goal of validating the...
Boston Scientific Closes Acquisition of Augmenix Inc.
News | Prostate Cancer | October 17, 2018
Boston Scientific Corp. announced the close of its acquisition of Augmenix Inc., developer of the SpaceOAR Hydrogel...
Varian Expands Cancer Care Portfolio With Noona Healthcare Acquisition
News | Patient Engagement | October 15, 2018
Varian announced the acquisition of privately-held software company Noona Healthcare, developer of a cloud-based,...
New Guideline for Prostate Cancer Supports Shortened Radiation Therapy
News | Prostate Cancer | October 12, 2018
Three prominent medical societies issued a new clinical guideline for physicians treating men with early-stage prostate...
Surgery, Radiation Therapy Equally Effective in Treating Oropharyngeal Cancer
News | Radiation Therapy | October 09, 2018
A new study by researchers at UT Southwestern Medical Center found no major long-term differences in the effectiveness...
Videos | Treatment Planning | October 08, 2018
Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology at Henry Ford Health System, descri